폐암 수술 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)

The future of the global lung cancer surgery market looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets. The global lung cancer surgery market is expected to reach an estimated $5.9 billion by 2031 with a CAGR of 3.4% from 2025 to 2031. The major drivers for this market are the rising occurrence of lung cancer, increasing consumer preference for minimally invasive surgeries, and increasing air pollution levels.

• Lucintel forecasts that, within the type category, surgical device is expected to witness the highest growth over the forecast period.
• Within the end-use category, ambulatory surgical center is expected to witness the highest growth over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Lung Cancer Surgery Market

Technological advancements, evolving patient requirements, and innovations in surgical techniques are key factors driving emerging trends in the lung cancer surgery market. These trends are enabling better patient outcomes while reducing the impacts on patients undergoing treatment.

• Robotic-Assisted Surgery: Robotic-assisted surgery enhances accuracy, precision, and control while minimizing scars, allowing for minimal incision procedures. This leads to reduced postoperative pain, shorter recovery times, and fewer complications. Additionally, robotic systems enable surgeons to perform complex operations with greater accuracy, improving patient outcomes and expanding the range of available treatments.
• Minimally Invasive Techniques: Minimally invasive techniques, such as video-assisted thoracoscopic surgery (VATS), are becoming increasingly common due to their benefits, including shorter healing times and fewer post-surgery complications. Smaller incisions made during these procedures reduce pain and enhance patient comfort. Patients experience quicker recovery, enabling them to return to daily activities faster.
• Integration of Advanced Imaging: Advanced imaging technologies, such as high-definition CT scans, PET scans, and intraoperative MRI, improve tumor localization and staging accuracy. These technologies contribute to better preoperative planning and provide real-time navigation during surgery, resulting in more precise interventions. The integration of innovative imaging modalities has significantly enhanced surgical outcomes.
• Personalized Medicine and Targeted Therapies: Personalized medicine involves creating individualized treatment plans based on a patient's unique genetic or molecular profile. Unlike standard approaches targeting general cancer mutations or pathways, targeted therapies are designed to address specific ones. The combination of personalized medicine and surgery is transforming treatment methods, providing more effective care tailored to the patient's specific needs.
• Enhanced Postoperative Care: Advanced postoperative care strategies, including sophisticated pain management techniques and rehabilitation programs, promote better recovery outcomes. Focused on minimizing complications, managing pain, and supporting overall well-being, these strategies are increasing patients' quality of life. They also facilitate faster recovery and contribute to full recovery after lung cancer surgery.

Significant advancements in lung cancer surgery, such as robotic-assisted surgeries, minimally invasive techniques, advanced imaging systems, personalized medicine, and improved postoperative care, are transforming the field. These trends improve surgical precision, enhance patient outcomes, and increase the effectiveness of treatments, thus reshaping the landscape of lung cancer surgery.

Recent Developments in the Lung Cancer Surgery Market

Recent advances in lung cancer surgery have been driven by technological advancements, improved techniques, and evolving patient care models. These improvements enhance the accuracy and effectiveness of surgical interventions, leading to better management of lung cancer cases.

• Adoption of Robotic-Assisted Surgery: Robotic-assisted surgery has revolutionized lung cancer treatment by providing surgeons with greater precision and control. Robotic systems enable less invasive operations with more accuracy, reducing the need for large incisions and minimizing post-operative pain. This innovation leads to faster healing, fewer complications, and improved surgical outcomes, benefiting both patients and healthcare providers.
• Integration of Advanced Imaging Technologies: New imaging technologies, such as HDCT scans, PET scans, and intraoperative MRIs, have improved tumor detection accuracy and localization efficiency. These methods enhance preoperative planning and provide real-time guidance during surgery, ensuring that interventions are precise and effective. The use of advanced imaging is increasing surgical accuracy, leading to better patient outcomes.
• Expansion of Minimally Invasive Techniques: Lung cancer surgery is being transformed by the expansion of minimally invasive techniques, such as Video-Assisted Thoracoscopic Surgery (VATS) and robotic-assisted thoracic surgeries. These techniques involve smaller incisions that cause less disruption to surrounding tissues, resulting in shorter healing times and fewer infections or complications. The shift from open procedures to less invasive methods improves patient comfort and promotes quicker recovery, making these procedures a preferred choice for both surgeons and patients.
• Advances in Personalized Medicine: Personalized medicine is significantly impacting lung cancer surgery by offering treatment plans tailored to individual patient profiles. Genetic and molecular profiling helps identify specific mutations and cancer characteristics, enabling targeted drug therapies in combination with surgical interventions. This approach makes treatment more effective for each patient's unique condition, resulting in more personalized and efficient care.
• Focus on Enhanced Postoperative Care: Postoperative care has been enhanced to support rapid recovery in lung cancer patients. This includes advanced pain management techniques, rehabilitative programs, and supportive care policies aimed at reducing complications and speeding up the healing process. These improvements enhance patients' overall health and quality of life after surgery, contributing to higher success rates during recovery.

The latest developments in lung cancer surgery, including robotic-assisted surgery, advanced imaging technologies, minimally invasive techniques, personalized medicine, and enhanced postoperative care, are driving significant improvements in the field. These advancements increase surgical precision and improve patient outcomes, shaping the future of lung cancer treatment.

Strategic Growth Opportunities for Lung Cancer Surgery Market

The lung cancer surgical market holds many strategic growth opportunities due to technological advancements, changing patient demands, and an increased emphasis on precision medicine. Various applications provide openings for innovation and investment toward market expansion, which would positively impact patients' welfare.

• Development of Advanced Surgical Technologies: The precision, control, and effectiveness of lung cancer surgeries are improved by the development and integration of advanced surgical technologies. The surgical results achieved are better due to the use of robotic systems and advanced imaging technologies, which allow for minimally invasive procedures and real-time navigation, among other benefits. These investments will drive market growth by offering better treatment alternatives and more surgical options.
• Expansion of Minimally Invasive Techniques: There is increasing demand for procedures with shorter recovery times, fewer complications, and greater patient comfort, which is pushing the use of minimally invasive approaches. This opportunity helps grow the market by providing efficient substitutes to open surgeries while also improving the overall patient experience during the treatment process.
• Integration of Personalized Medicine: Personalized medicine allows for consideration of individual characteristics before proceeding with any form of surgery, thus ensuring the most effective treatment. This system focuses on unique factors, such as the specific characteristics of a tumor, which differentiate it from others. The integration of personalized medicine drives market growth by enabling more focused and effective treatments.
• Enhancement of Postoperative Care and Rehabilitation: Improved postoperative care and rehabilitation programs contribute to faster healing and enhanced outcomes for patients. This opportunity includes advances in pain management, supportive care, and rehabilitation strategies, which lead to improved quality of life and reduced morbidity. Consequently, investing in postoperative care promotes market expansion by addressing key factors related to patient recovery and overall health.
• Expansion into Emerging Markets: Expansion into emerging markets presents an opportunity for market growth as these regions invest in improving cancer care infrastructure and access to advanced treatments. This will ensure more treatment options through innovative technologies used during surgical operations, which, in turn, drives market growth and improves treatment quality in these regions.

Leveraging strategic opportunities in the lung cancer surgery market, such as the development of advanced surgical tools, minimally invasive techniques, integration of personalized medicine, better postoperative care, and expansion into emerging markets, can lead to a significant increase in market share. By doing so, there is enormous potential for innovation, improved patient outcomes, and a transformative future for lung cancer treatments.

Lung Cancer Surgery Market Driver and Challenges

The development of the lung cancer surgery market is shaped by various drivers and challenges that influence its growth. Technological advancements, the increasing demand for minimally invasive procedures, and the rise of personalized medicine are some of the key drivers. However, high costs, complex surgical procedures, and unequal access to healthcare pose significant challenges to the sector. Understanding these factors is crucial for achieving success in this dynamic environment.

Factors Driving the Lung Cancer Surgery Market:

1. Technological Advancements: Technological innovations are making lung cancer surgeries more precise, which leads to improved outcomes and faster recovery times. Robotic-assisted systems and advanced imaging technologies support minimally invasive procedures and provide real-time guidance during surgeries. These advancements enhance patient experiences and contribute to the rapid growth of the market, as they improve the effectiveness and accessibility of lung cancer surgery.

2. Demand for Less Invasive Procedures: The growing demand for minimally invasive surgery has led to the adoption of techniques such as Video-Assisted Thoracoscopic Surgery (VATS) and robotic-assisted surgery. These procedures offer several advantages, including reduced pain, quicker recovery times, and fewer complications, all of which drive the market's growth. As patients increasingly prefer less invasive options, the shift toward these techniques continues to grow.

3. Advances in Personalized Medicine: Personalized medicine, which tailors treatments based on an individual's genetic and molecular profile, is revolutionizing the lung cancer surgery landscape. This approach enhances the effectiveness of surgical interventions by targeting the specific needs of each patient. By offering customized treatment plans, personalized medicine improves overall surgical outcomes and supports market growth.

4. Healthcare Infrastructure Expansion: The expansion of healthcare infrastructure plays a crucial role in the growth of the lung cancer surgery market. Investments in cancer care facilities and the availability of advanced treatments enable broader access to cutting-edge surgical techniques. The development of healthcare infrastructure, especially in emerging markets, drives the adoption of innovative surgical technologies and contributes to improved treatment options.

5. Emphasis on Better Patient Outcomes: There is a growing emphasis on improving patient outcomes, both during surgery and in post-operative care. Advancements in post-surgery rehabilitation and recovery techniques increase the chances of survival and quality of life for patients. As a result, there is a greater demand for effective and innovative surgical procedures that can lead to better overall treatment results.

Challenges in the Lung Cancer Surgery Market:

1. High Initial Costs: One of the main challenges facing the lung cancer surgery market is the high cost of advanced surgical technologies and treatments. These costs can be prohibitive, particularly in resource-constrained settings, limiting accessibility and affordability. Addressing cost barriers and finding cost-effective solutions will be critical for expanding market penetration and improving access to advanced treatments.

2. Complexity of Surgical Procedures: Lung cancer surgeries are highly complex and require specialized skills and expertise. The need for advanced training and education for healthcare professionals can limit the availability of these procedures, particularly in underserved areas. The complexity of the surgeries also creates challenges in terms of equipment and surgical team readiness, which may affect patient access to these critical treatments.

3. Disparities in Healthcare Access: Healthcare disparities exist in terms of access to lung cancer surgeries, with some regions or populations having limited access to advanced surgical treatments. These disparities hinder the broader adoption of innovative procedures, leading to unequal treatment outcomes. Addressing these regional differences and ensuring fair distribution of healthcare resources will be essential to expanding market reach and improving global treatment outcomes.

The lung cancer surgery market is primarily driven by technological advancements, the rising demand for minimally invasive procedures, the growth of personalized medicine, the expansion of healthcare infrastructure, and an emphasis on improving patient outcomes. However, challenges such as high costs, the complexity of surgical procedures, and disparities in healthcare access continue to impact market dynamics. Addressing these challenges while capitalizing on the market drivers will be essential for advancing lung cancer surgery practices and expanding market opportunities.

List of Lung Cancer Surgery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies lung cancer surgery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lung cancer surgery companies profiled in this report include-

• Scanlan International
• Ethicon Endo Surgery
• Covidien
• Trokamed
• Angiodynamics
• Richard Wolf
• BSD Medical
• Siemens Healthcare
• Accuray
• Neomend

Lung Cancer Surgery by Segment

The study includes a forecast for the global lung cancer surgery market by product type, surgery, end use, and region.

Lung Cancer Surgery Market by Product Type [Analysis by Value from 2019 to 2031]:

• Surgical Devices
• Endosurgical Equipment
• Monitoring or Visualizing Equipment

Lung Cancer Surgery Market by Surgery [Analysis by Value from 2019 to 2031]:

• Robotic Surgery
• Thoracotomy
• Video Assisted Surgery
• Percutaneous Surgery
• Endobronchial Surgery

Lung Cancer Surgery Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Specialty Cancer Care Centers
• Ambulatory Surgical Centers
• Others

Lung Cancer Surgery Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Lung Cancer Surgery Market

Recent developments in lung cancer surgery have been characterized by significant advancements in surgical techniques, technology, and patient management strategies across various countries. These developments are improving the quality of treatments, leading to better patient outcomes and fostering innovation. This brief provides an overview of some key changes that have taken place within the lung cancer surgery market in countries such as the United States, China, Germany, India, and Japan.

• United States: Innovations in American lung cancer surgery include increased use of minimally invasive procedures like robotic-assisted surgery and video-assisted thoracoscopic surgery (VATS). These methods have several advantages over traditional open surgeries, including shorter recovery times and fewer complications. Additionally, there has been a surge in targeted therapies and personalized medicine that incorporates genomic data in planning surgeries. Another notable advancement is the development of new imaging technologies, such as high-definition CT scans and PET scans, which provide improved preoperative staging and intra-operative navigation for more precise and effective interventions.
• China: China has made remarkable strides in lung cancer surgery through the adoption of advanced surgical technologies and minimally invasive approaches. This expansion includes the use of robotic-assisted surgery, which allows for more precise and controlled procedures. Improving surgical outcomes is also being achieved through multidisciplinary efforts that bring together oncologists, radiologists, surgeons, and other specialists. Additionally, the improvement of postoperative care systems and rehabilitation has led to faster recovery rates and fewer complications following surgeries. These efforts are aimed at improving access to modern treatment modalities and, as a result, enhancing prognosis for patients diagnosed with lung cancer.
• Germany: Germany is leading in cutting-edge surgical technologies and techniques for the treatment of lung cancer patients. One recent development is the use of augmented reality during intra-surgical procedures, such as the introduction of intraoperative MRI, which increases accuracy during operations. The country emphasizes minimally invasive options, particularly robotic-assisted thoracic surgery, which ensures quicker recovery and reduced postoperative pain. Germany's investment in research and innovation in cancer treatment has resulted in significant improvements in surgical procedures. Additionally, the nation's cancer care programs include extensive training for physicians across various specialties.
• India: In India, recent developments in lung cancer surgery are marked by improved access to advanced surgical technologies, largely due to better training for healthcare professionals. Both the public and private sectors in India are driving the demand for minimally invasive techniques, including VATS and robotic-assisted surgery. There is also a concerted effort to improve cancer care infrastructure, including the establishment of specialized cancer centers equipped with the latest imaging technology. Additionally, there is a growing focus on improving patient outcomes through enhanced postoperative care and rehabilitation programs. These advances are helping to increase treatment options and improve outcomes in cases where the lungs are affected by cancer.
• Japan: Japan has made significant strides in lung cancer surgery due to the use of advanced surgical techniques and technologies. Robotic-assisted thoracic surgery, which is at the forefront in Japan, has brought greater precision and more minimally invasive options for patients. Recent developments focus on improving surgical outcomes through high-definition imaging and real-time navigation systems. Japan has also integrated personalized medicine and targeted therapies into surgical methods, driven by the nation's strong commitment to cancer treatment research and development. In Japan, early detection and minimally invasive surgery are contributing to higher survival rates and improved quality of life for patients with lung cancer.

Features of the Global Lung Cancer Surgery Market

Market Size Estimates: Lung cancer surgery market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Lung cancer surgery market size by product type, surgery, end use, and region in terms of value ($B).

Regional Analysis: Lung cancer surgery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, surgeries, end uses, and regions for the lung cancer surgery market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lung cancer surgery market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the lung cancer surgery market by product type (surgical devices, endosurgical equipment, and monitoring or visualizing equipment), surgery (robotic surgery, thoracotomy, video assisted surgery, percutaneous surgery, and endobronchial surgery), end use (hospitals, specialty cancer care centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Lung Cancer Surgery Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Lung Cancer Surgery Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Lung Cancer Surgery Market by Product Type
  • 3.3.1: Surgical Devices
  • 3.3.2: Endosurgical Equipment
  • 3.3.3: Monitoring or Visualizing Equipment
• 3.4: Global Lung Cancer Surgery Market by Surgery
  • 3.4.1: Robotic Surgery
  • 3.4.2: Thoracotomy
  • 3.4.3: Video Assisted Surgery
  • 3.4.4: Percutaneous Surgery
  • 3.4.5: Endobronchial Surgery
• 3.5: Global Lung Cancer Surgery Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Specialty Cancer Care Centers
  • 3.5.3: Ambulatory Surgical Centers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Lung Cancer Surgery Market by Region
• 4.2: North American Lung Cancer Surgery Market
  • 4.2.1: North American Lung Cancer Surgery Market by Product Type: Surgical Devices, Endosurgical Equipment, and Monitoring or Visualizing Equipment
  • 4.2.2: North American Lung Cancer Surgery Market by End Use: Hospitals, Specialty Cancer Care Centers, Ambulatory Surgical Centers, and Others
• 4.3: European Lung Cancer Surgery Market
  • 4.3.1: European Lung Cancer Surgery Market by Product Type: Surgical Devices, Endosurgical Equipment, and Monitoring or Visualizing Equipment
  • 4.3.2: European Lung Cancer Surgery Market by End Use: Hospitals, Specialty Cancer Care Centers, Ambulatory Surgical Centers, and Others
• 4.4: APAC Lung Cancer Surgery Market
  • 4.4.1: APAC Lung Cancer Surgery Market by Product Type: Surgical Devices, Endosurgical Equipment, and Monitoring or Visualizing Equipment
  • 4.4.2: APAC Lung Cancer Surgery Market by End Use: Hospitals, Specialty Cancer Care Centers, Ambulatory Surgical Centers, and Others
• 4.5: ROW Lung Cancer Surgery Market
  • 4.5.1: ROW Lung Cancer Surgery Market by Product Type: Surgical Devices, Endosurgical Equipment, and Monitoring or Visualizing Equipment
  • 4.5.2: ROW Lung Cancer Surgery Market by End Use: Hospitals, Specialty Cancer Care Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Lung Cancer Surgery Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Lung Cancer Surgery Market by Surgery
  • 6.1.3: Growth Opportunities for the Global Lung Cancer Surgery Market by End Use
  • 6.1.4: Growth Opportunities for the Global Lung Cancer Surgery Market by Region
• 6.2: Emerging Trends in the Global Lung Cancer Surgery Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Lung Cancer Surgery Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Lung Cancer Surgery Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Scanlan International
• 7.2: Ethicon Endo Surgery
• 7.3: Covidien
• 7.4: Trokamed
• 7.5: Angiodynamics
• 7.6: Richard Wolf
• 7.7: BSD Medical
• 7.8: Siemens Healthcare
• 7.9: Accuray
• 7.10: Neomend